MAPT and Alzheimer disease: In AD, correlation of phospho-S396-tau, phospho-T181-tau, and Aβ1–42 levels in neural-derived blood exosomes with AD progress was described and, interestingly, in the study of Fiandaca et al., such proteins could predict AD up to 10 years prior to clinical onset [58,60].